Cell-Freezing Devices Are Not Strictly Needed to Start an Autologous Hematopoietic Transplantation Program: Non-Cryopreserved Peripheral Blood Stem Cells Can be Used to Restore Hematopoiesis after High Dose Chemotherapy: A Multicenter Experience in 268 Autografts in Patients with Multiple Myeloma or Lymphoma. Study on Behalf of the Latin-American Bone Marrow Transplantation Group (LABMT)
Amado Karduss(Instituto de Cancerología Las Américas), Juan Alejo Jimenez(Instituto de Cancerología Las Américas), Guillermo J. Ruiz‐Delgado(Clínica Ruiz), Samantha Galindo-Becerra(Clínica Ruiz), Nancy Labastida-Mercado(Clínica Ruiz), Guillermo J. Ruíz‐Argüelles(Universidad Popular Autónoma del Estado de Puebla), Luis Rodolfo Manosalvas Gómez(Amec Foster Wheeler (United States)), Angelica Maria Cardona(Instituto de Cancerología Las Américas), Pedro Reyes(Instituto de Cancerología Las Américas), Rosendo Lurı́a-Pérez(Instituto de Cancerología Las Américas)
Cited by 16
Related Papers
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
|Haematologica|2021|236
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update
|Transplantation and Cellular Therapy|2024|67
Day care and selected employee work behaviors.
|PubMed|1976|62
A multi-gene panel study in hereditary breast and ovarian cancer in Colombia
|Familial Cancer|2017|49
An Application of Job Enrichment in a Civil Service Setting: A Demonstration Study
|Public Personnel Management|1975|9